Cytokine release and gastrointestinal symptoms after gluten challenge in celiac disease

Celiac disease (CeD), caused by immune reactions to cereal gluten, is treated with gluten -elimination diets. Within hours of gluten exposure, either perorally or extraorally by intradermal injection, treated patients experience gastrointestinal symptoms. To test whether gluten exposure leads to sys...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Science advances 2019-08, Vol.5 (8), p.eaaw7756-eaaw7756
Hauptverfasser: Goel, Gautam, Tye-Din, Jason A, Qiao, Shuo-Wang, Russell, Amy K, Mayassi, Toufic, Ciszewski, Cezary, Sarna, Vikas K, Wang, Suyue, Goldstein, Kaela E, Dzuris, John L, Williams, Leslie J, Xavier, Ramnik J, Lundin, Knut E A, Jabri, Bana, Sollid, Ludvig M, Anderson, Robert P
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Celiac disease (CeD), caused by immune reactions to cereal gluten, is treated with gluten -elimination diets. Within hours of gluten exposure, either perorally or extraorally by intradermal injection, treated patients experience gastrointestinal symptoms. To test whether gluten exposure leads to systemic cytokine production time -related to symptoms, series of multiplex cytokine measurements were obtained in CeD patients after gluten challenge. Peptide injection elevated at least 15 plasma cytokines, with IL-2, IL-8, and IL-10 being most prominent (fold-change increase at 4 hours of 272, 11, and 1.2, respectively). IL-2 and IL-8 were the only cytokines elevated at 2 hours, preceding onset of symptoms. After gluten ingestion, IL-2 was the earliest and most prominent cytokine (15-fold change at 4 hours). Supported by studies of patient-derived gluten-specific T cell clones and primary lymphocytes, our observations indicate that gluten-specific CD4 T cells are rapidly reactivated by antigen -exposure likely causing CeD-associated gastrointestinal symptoms.
ISSN:2375-2548
2375-2548
DOI:10.1126/sciadv.aaw7756